Skip to main content

Breadcrumb

  1. Home

Fall 2023

Valid for Measure Submission

Oncology: Medical and Radiation – Plan of Care for Pain

  • This measure looks at the percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain. This measure is to be submitted at each denominator eligible visit occurring during the performance period for patients with a diagnosis of cancer and in which pain is present who are seen during the performance period / measurement period. The time period for data collection is intended to be 12 consecutive months.

     

    CBE ID
    0383

Pediatric Lower Respiratory Infection Readmission Measure

  • This measure calculates case-mix-adjusted readmission rates, defined as the percentage of admissions followed by 1 or more readmissions within 30 days, following hospitalization for lower respiratory infection (LRI) in patients less than 18 years old. The measure covers patients discharged from general acute care hospitals, including children’s hospitals.

    CBE ID
    2414

Risk-Adjusted Operative Mortality for Aortic Valve Replacement (AVR)

  • Percent of patients aged 18 years and older undergoing Aortic Valve Replacement (AVR) who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0120

Risk-Adjusted Operative Mortality for Aortic Valve Replacement (AVR) + CABG Surgery

  • Percent of patients aged 18 years and older undergoing combined AVR and CABG who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0123

Risk-Adjusted Operative Mortality for CABG

  • Percent of patients aged 18 years and older undergoing isolated CABG who die, including both 1) all deaths occurring during the hospitalization in which the CABG was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0119

Risk-Adjusted Operative Mortality for Mitral Valve (MV) Replacement

  • Percent of patients aged 18 years and older undergoing MV Replacement who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0121

Risk-Adjusted Operative Mortality for Mitral Valve (MV) Replacement + CABG Surgery

  • Percent of patients aged 18 years and older undergoing combined MV Replacement and CABG who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0122

Spring 2023 Post-Comment Meeting

Following the conclusion of the Spring 2023 public comment period, the project committee reviews submitted comments. After its review, the committee may choose to revise its recommendations within in response to a specific comment or series of comments. In addition the project committee will re-vote on measures in which consensus was not reached during the Spring 2023 measure evaluaiton meeting. Any revisions will be reflected in the final report.